Pharmacy Articles

Pharmacy

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kalapatapu RK et al. - Antipsychotic medications have a modest effect on the neuropsychiatric symptoms of dementia, but product labels warn of the excess risk of death and morbidity associated with their use in older patients. As such, these agents should not be the first choice for the treatment of behavioral and psychotic symptoms of dementia. Nevertheless, a trial of these agents may be indicated in instances in which the severity of symptoms is extreme, or symptoms do not respond to nonpharmacologic methods or other medications...There is no evidence to suggest differences in effectiveness between atypical and conventional antipsychotics; therefore, the choice of an antipsychotic for neuropsychiatric symptoms often relies on side effect profile and individual patient circumstances. Extrapyramidal symptoms and QTc prolongation are concerns with conventional antipsychotic agents. The incidence of cerebrovascular events with either atypical or conventional antipsychotics appears increased compared with placebo. A discussion of the risk-benefit ratio of antipsychotics with the patient's family and/or caregivers should precede the decision to use these agents.

Related Articles

Prevalence of dementia and major dementia subtypes in Spanish populations: A reanalysis of dementia prevalence surveys, 1990-2008
BMC Neurology, 10/23/09    Relevance Score: 94%

High Prevalence of Orthostatic Hypotension in Mild Dementia
Dementia and Geriatric Cognitive Disorders, 10/15/09    Relevance Score: 93%

Predicting dementia: role of dementia risk indices
Future Neurology, 10/02/09    Relevance Score: 93%

Lipids peroxidation markers in Alzheimer's disease and vascular dementia
Geriatrics and Gerontology International, 11/17/09    Relevance Score: 91%

Promiscuous modulation of ion channels by anti-psychotic and anti-dementia medications
Medical Hypotheses, 10/05/09    Relevance Score: 91%

Today in Neuro/Psych pharmacology...keeping you current

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

Phenylephrine but not Ephedrine Reduces Frontal Lobe Oxygenation Following Anesthesia-Induced Hypotension
Neurocritical Care , 12/16/09

An Herbal Nasal Drop Enhanced Frontal and Anterior Cingulate Cortex Activity
Evidence-based Complementary and Alternative Medicine , 12/16/09